Align Technology
Market Cap
US$17.1b
Last Updated
2019/10/19 23:31 UTC
Data Sources
Company Financials +
Executive Summary
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide.
Snowflake
Fundamentals
Outstanding track record with flawless balance sheet.
Similar Companies
Share Price & News
How has Align Technology's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
6.9%
ALGN
1.9%
US Medical Equipment
0.4%
US Market
1 Year Return
-31.6%
ALGN
15.6%
US Medical Equipment
6.9%
US Market
Return vs Industry: ALGN underperformed the US Medical Equipment industry which returned 15.6% over the past year.
Return vs Market: ALGN underperformed the US Market which returned 6.9% over the past year.
Shareholder returns
| ALGN | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.9% | 1.9% | 0.4% |
| 30 Day | 18.6% | -1.6% | -1.2% |
| 90 Day | -23.9% | 0.01% | -0.4% |
| 1 Year | -31.6%-31.6% | 16.5%15.6% | 9.3%6.9% |
| 3 Year | 139.0%139.0% | 72.1%66.9% | 45.8%36.4% |
| 5 Year | 315.3%315.3% | 125.8%100.8% | 62.9%45.1% |
Price Volatility Vs. Market
How volatile is Align Technology's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall St
Should You Think About Buying Align Technology, Inc. (NASDAQ:ALGN) Now?2 weeks ago | Simply Wall St
Align Technology, Inc. (NASDAQ:ALGN) Is Employing Capital Very Effectively4 weeks ago | Simply Wall St
Introducing Align Technology (NASDAQ:ALGN), The Stock That Zoomed 251% In The Last Five YearsValuation
Is Align Technology undervalued compared to its fair value and its price relative to the market?
29.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: ALGN ($213.88) is trading below our estimate of fair value ($301.29)
Significantly Undervalued: ALGN is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: ALGN is good value based on its PE Ratio (41x) compared to the Medical Equipment industry average (42.2x).
PE vs Market: ALGN is poor value based on its PE Ratio (41x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
Low PEG Ratio: ALGN is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: ALGN is overvalued based on its PB Ratio (12.4x) compared to the US Medical Equipment industry average (3.8x).
Next Steps
Future Growth
How is Align Technology forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
19.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALGN's forecast earnings growth (19.2% per year) is above the savings rate (2.7%).
Earnings vs Market: ALGN's earnings (19.2% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: ALGN's earnings are forecast to grow, but not significantly.
Revenue vs Market: ALGN's revenue (17.9% per year) is forecast to grow faster than the US market (7.2% per year).
High Growth Revenue: ALGN's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: ALGN's Return on Equity is forecast to be high in 3 years time (34.3%)
Next Steps
Past Performance
How has Align Technology performed over the past 5 years?
23.9%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: ALGN's earnings have grown significantly by 23.9% per year over the past 5 years.
Accelerating Growth: ALGN's earnings growth over the past year (41.5%) exceeds its 5-year average (23.9% per year).
Earnings vs Industry: ALGN earnings growth over the past year (41.5%) exceeded the Medical Equipment industry 28.2%.
Return on Equity
High ROE: ALGN's Return on Equity (30.4%) is considered high.
Return on Assets
ROA vs Industry: ALGN has a higher Return on Assets than the Medical Equipment industry average last year.
Return on Capital Employed
ROCE Improving: ALGN has significantly improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Align Technology's financial position?
Financial Position Analysis
Short Term Liabilities: ALGN's short term assets ($1.5B) exceeds its short term liabilities ($789.0M)
Long Term Liabilities: ALGN's short term assets (1.5B) exceeds its long term liabilities (183.3M)
Debt to Equity History and Analysis
Debt Level: ALGN is debt free.
Reducing Debt: ALGN has not had any debt for past 5 years.
Debt Coverage: ALGN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ALGN has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: ALGN has a high level of physical assets or inventory.
Debt Coverage by Assets: ALGN's debt is covered by short term assets (assets are 102553578177178921.163020x debt).
Next Steps
Dividend
What is Align Technology's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate ALGN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ALGN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if ALGN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALGN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ALGN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Align Technology's salary, the management and board of directors tenure and is there insider trading?
3.4yrs
Average management tenure
CEO
Joe Hogan (62yo)
4.3yrs
Tenure
US$41,758,338
Compensation
Mr. Joseph M. Hogan, also known as Joe, has been Chief Executive Officer and President of Align Technology, Inc. since June 01, 2015. Mr. Hogan serves as a Senior Advisor of ABB Ltd at ABB S.A. He served a ...
CEO Compensation Analysis
Compensation vs. Market: Joe's total compensation ($USD41.76M) is about average for companies of similar size in the US market ($USD11.18M).
Compensation vs Earnings: Joe's compensation has increased by more than 20% in the past year.
Management Age and Tenure
3.4yrs
Average Tenure
52yo
Average Age
Experienced Management: ALGN's management team is considered experienced (3.4 years average tenure).
Board Age and Tenure
13.7yrs
Average Tenure
62.5yo
Average Age
Experienced Board: ALGN's board of directors are seasoned and experienced ( 13.7 years average tenure).
Insider Trading
Insider Buying: ALGN insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Shares | 900 |
| Max Price | US$183.60 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 10,000 |
| Max Price | US$177.64 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 4,157 |
| Max Price | US$179.54 |
| Entity | Individual |
| Shares | 564 |
| Max Price | US$177.04 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 30,000 |
| Max Price | US$183.50 |
| Entity | Individual |
| Role | Head of Marketing Senior VP & Chief Marketing |
| Shares | 1,100 |
| Max Price | US$188.11 |
| Entity | Individual |
| Role | Chief Executive Officer President |
| Shares | 4,995 |
| Max Price | US$199.83 |
| Entity | Individual |
| Role | Chief Financial Officer CFO & Senior VP of Global Finance |
| Shares | 2,374 |
| Max Price | US$286.91 |
| Entity | Individual |
| Role | Chairman of the Board Independent Chairman |
| Shares | 9,734 |
| Max Price | US$296.65 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 3,000 |
| Max Price | US$313.13 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 12,000 |
| Max Price | US$307.76 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 3,115 |
| Max Price | US$315.17 |
| Entity | Individual |
| Shares | 3,291 |
| Max Price | US$331.89 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 5,000 |
| Max Price | US$320.00 |
| Entity | Individual |
| Shares | 3,214 |
| Max Price | US$323.00 |
| Entity | Individual |
| Shares | 19,495 |
| Max Price | US$328.27 |
| Entity | Individual |
| Shares | 15,000 |
| Max Price | US$328.00 |
| Entity | Individual |
| Role | Senior Key Executive Senior VP & MD of Asia Pacific |
| Shares | 13,500 |
| Max Price | US$325.00 |
| Entity | Individual |
| Role | Senior Key Executive Senior VP & MD of Asia Pacific |
| Shares | 3,560 |
| Max Price | US$325.00 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 20,000 |
| Max Price | US$259.00 |
| Entity | Individual |
| Shares | 400 |
| Max Price | US$255.52 |
| Entity | Individual |
| Role | Senior Key Executive Senior VP & MD of Asia Pacific |
| Shares | 1,250 |
| Max Price | US$254.58 |
| Entity | Individual |
| Shares | 8,764 |
| Max Price | US$228.05 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 10,000 |
| Max Price | US$231.82 |
| Entity | Individual |
| Shares | 5,000 |
| Max Price | US$223.92 |
Ownership Breakdown
Management Team
Joe Hogan (62yo)
President
- Tenure: 4.3yrs
- Compensation: US$41.76m
Emory Wright (49yo)
Senior Vice President of Global Operations
- Tenure: 11.8yrs
- Compensation: US$3.15m
Julie Coletti
Senior VP and Chief Legal & Regulatory Officer
- Tenure: 0.4yrs
Julie Tay (52yo)
Senior VP & MD of Asia Pacific
- Tenure: 6.6yrs
Zelko Relic (54yo)
CTO and Senior VP of Global Research & Development
- Tenure: 1.7yrs
- Compensation: US$3.08m
Simon Beard (52yo)
MD for Americas Region & Senior VP
- Tenure: 4yrs
Stuart Hockridge (47yo)
Senior Vice President of Global Human Resources
- Tenure: 3.4yrs
- Compensation: US$3.35m
John Morici (52yo)
CFO & Senior VP of Global Finance
- Tenure: 2.9yrs
- Compensation: US$3.36m
Vamsi Pudipeddi (47yo)
Senior VP & Chief Marketing
- Tenure: 0.7yrs
Shirley Stacy
Vice President of Corporate Communications & Investor Relations
- Tenure: 0yrs
Board Members
Joe Lacob (63yo)
Independent Director
- Tenure: 22.2yrs
- Compensation: US$365.05k
Greg Santora (68yo)
Independent Director
- Tenure: 16.3yrs
- Compensation: US$390.55k
Tim Prescott (63yo)
Director
- Tenure: 17.6yrs
- Compensation: US$355.05k
Sue Siegel (58yo)
Independent Director
- Tenure: 2.6yrs
- Compensation: US$359.22k
Joe Hogan (62yo)
President
- Tenure: 4.3yrs
- Compensation: US$41.76m
Greg Morrow (67yo)
Independent Director
- Tenure: 13.7yrs
- Compensation: US$382.05k
Ray Larkin (70yo)
Independent Chairman
- Tenure: 13.7yrs
- Compensation: US$536.93k
Warren Thaler (56yo)
Independent Director
- Tenure: 15.3yrs
- Compensation: US$373.55k
Andrea Saia (61yo)
Independent Director
- Tenure: 6.3yrs
- Compensation: US$382.05k
Kevin Dallas (55yo)
Independent Director
- Tenure: 1.6yrs
- Compensation: US$437.72k
Company Information
Align Technology, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Align Technology, Inc.
- Ticker: ALGN
- Exchange: NasdaqGS
- Founded: 1997
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$17.083b
- Shares outstanding: 79.87m
- Website: https://www.aligntech.com
Number of Employees
Location
- Align Technology, Inc.
- 2820 Orchard Parkway
- San Jose
- California
- 95134
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ALGN | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jan 2001 |
| AFW | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 2001 |
| 0HCK | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 2001 |
| ALGN * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 2001 |
| ALGN | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 2001 |
Biography
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dent ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/19 23:31 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.